Form 8-K - Current report:
SEC Accession No. 0001493152-25-002389
Filing Date
2025-01-15
Accepted
2025-01-15 16:30:11
Documents
16
Period of Report
2025-01-09
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 54260
2 ex3-1.htm EX-3.1 44220
3 ex3-1_001.jpg GRAPHIC 291500
4 ex3-1_002.jpg GRAPHIC 126024
  Complete submission text file 0001493152-25-002389.txt   862945

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE mgrx-20250109.xsd EX-101.SCH 3033
6 XBRL LABEL FILE mgrx-20250109_lab.xml EX-101.LAB 34240
7 XBRL PRESENTATION FILE mgrx-20250109_pre.xml EX-101.PRE 24177
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3925
Mailing Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248
Business Address 15110 DALLAS PKWY, SUITE 600 DALLAS TX 75248 (833) 626-4679
MANGOCEUTICALS, INC. (Filer) CIK: 0001938046 (see all company filings)

EIN.: 873841292 | State of Incorp.: TX | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41615 | Film No.: 25533249
SIC: 8090 Services-Misc Health & Allied Services, NEC
(CF Office: 03 Life Sciences)